Canada's #1 Community Marketplace
Home Blog News Announcements Pricing Register Free
business

TuHURA Biosciences Receives FDA IND Clearance For TBS-2025 In AML

📰 Rttnews 🕐 1 min read 📅 September 14, 2026 👁 1 views
TuHURA Biosciences Receives FDA IND Clearance For TBS-2025 In AML
TuHURA Biosciences (HURA) received FDA clearance for its IND application for TBS-2025, a VISTA-inhibiting antibody for relapsed/refractory mutNPM1 AML. The Phase 1b study will evaluate TBS-2025 as monotherapy in patients who failed menin inhibitor therapy.
Read full article on Rttnews

Related News

🤖
GoBazaar Assistant
Search listings, jobs, events & more
👋 Hi! I can help you find anything on GoBazaar.
Try asking me something like:
"Room for rent under $800 in Calgary"
Select Location
All Canada
Alberta
British Columbia
Manitoba
New Brunswick
Nova Scotia
Ontario
Quebec
Saskatchewan